Loading...
India's amphotericin imports from BRAZIL total $271.0K across 8 shipments from 5 foreign suppliers. NEWARIS LIFESCIENCES leads with $171.6K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include EMCURE PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for amphotericin — a diversified sourcing base with multiple active suppliers from BRAZIL.
NEWARIS LIFESCIENCES is the leading Amphotericin supplier from BRAZIL to India, with import value of $171.6K across 1 shipments. The top 5 suppliers — NEWARIS LIFESCIENCES, M/S SUN FARMACEUTICA DO BRASIL LTDA, EUROFARMA LABORATORIOS S A, M/S. T & E ANALITICA CENTRO CIENTIF, NEWARIS LIFECENCES — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWARIS LIFESCIENCES | $171.6K | 1 | 63.3% |
| 2 | M/S SUN FARMACEUTICA DO BRASIL LTDA | $55.6K | 3 | 20.5% |
| 3 | EUROFARMA LABORATORIOS S A | $37.2K | 1 | 13.7% |
| 4 | M/S. T & E ANALITICA CENTRO CIENTIF | $6.1K | 2 | 2.3% |
| 5 | NEWARIS LIFECENCES | $401 | 1 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED | $171.6K | 1 | 63.3% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $55.6K | 3 | 20.5% |
| 3 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED |
BRAZIL → India trade corridor intelligence
The Brazil to India shipping corridor has experienced stable conditions in 2025–2026. Sea freight from Brazil to India typically takes around 30 days, while air freight is approximately 7 days. The majority of shipments are transported by sea (80%), with a smaller portion by air (20%). Port congestion at major Indian ports such as Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra has been minimal, ensuring timely deliveries. Freight rates have remained consistent, and the exchange rate between the Indian Rupee (INR) and Brazilian Real has been stable, facilitating predictable costs for importers.
The Production Linked Incentive (PLI) scheme introduced by the Indian government aims to boost domestic manufacturing and reduce reliance on imports. This policy may impact the volume of finished formulation imports from Brazil, as domestic production increases. However, the PLI scheme is primarily focused on domestic manufacturing, and its direct impact on imports of specialized formulations like Amphotericin is yet to be fully realized.
| $37.2K |
| 1 |
| 13.7% |
| 4 | SUN PHARMACEUTICAL MEDICARE LIMITED | $6.1K | 2 | 2.3% |
| 5 | AZIDUS LABORATORIES LIMITED | $401 | 1 | 0.1% |
India and Brazil maintain a cordial trade relationship, with ongoing discussions to enhance bilateral trade, including in the pharmaceutical sector. While there are no specific Free Trade Agreements (FTAs) between the two countries, both nations are members of the World Trade Organization (WTO), which facilitates trade through agreed-upon rules and regulations. Efforts to recognize each other's Good Manufacturing Practices (GMP) and streamline pharmaceutical trade are ongoing, aiming to reduce barriers and promote smoother trade flows.
The estimated landed cost for importing finished Amphotericin formulations from Brazil to India is calculated as follows:
The total landed cost per unit is calculated by summing the above components.
CDSCO registration, import licensing, and quality testing requirements
To import finished pharmaceutical formulations containing Amphotericin into India, the importing company must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The application process involves submitting detailed product information, including manufacturing details, quality control measures, and clinical data. The registration certificate is valid for three years from the date of issue. The Import License, issued by the Drug Controller General of India (DCGI), is also valid for three years. The application process typically takes several months, depending on the completeness of the submitted documentation and the CDSCO's evaluation process.
Imported pharmaceutical formulations must undergo quality testing at CDSCO-approved laboratories. This includes batch-wise testing, where samples from each batch are analyzed to ensure compliance with Indian Pharmacopoeia standards. The Certificate of Analysis (CoA) from the exporting country’s laboratory must accompany the shipment. Stability data, particularly for ICH Zone IV conditions, is required to demonstrate the product's shelf-life under Indian climatic conditions. Port inspection by customs drug inspectors is mandatory to verify the authenticity and quality of the imported products.
Recent regulatory updates by CDSCO have emphasized stricter compliance for imported medicines, including mandatory import registration and licensing. The introduction of the Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing, potentially impacting the volume of finished formulation imports. Bilateral agreements between India and Brazil may facilitate smoother trade relations, but specific details are yet to be finalized.
Market demand, customs duty structure, and competitive landscape · Import duty: 10%
India imports finished Amphotericin formulations to meet the demand for specialized dosage forms and patented formulations not available domestically. The market size for Amphotericin formulations in India is substantial, with a significant portion of the demand met through imports. Domestic manufacturers may lack the capacity or technology to produce certain specialized formulations, leading to reliance on imports.
The total landed duty for importing finished pharmaceutical formulations under HS Code 30049029 into India includes:
This results in a cumulative duty of approximately 23.6% on the CIF (Cost, Insurance, and Freight) value.
India sources finished Amphotericin formulations from Brazil due to the availability of specialized dosage forms and patented formulations not produced domestically. Brazil's pharmaceutical industry offers high-quality products that meet international standards, providing a competitive advantage over other suppliers. While other countries like China, Germany, and the US also supply these formulations, Brazil's unique offerings and quality standards make it a preferred source for Indian importers.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports Amphotericin formulations from Brazil due to the availability of specialized dosage forms and patented formulations not produced domestically. Brazil's pharmaceutical industry offers high-quality products that meet international standards, providing a competitive advantage over other suppliers. The unique formulations and quality standards from Brazil fulfill specific market needs in India, making it a preferred source for importers.
When compared to other origins like China, the European Union, and the United States, Brazil offers competitive pricing and high-quality products. Brazil's adherence to international quality standards and its ability to provide specialized formulations give it a unique advantage over other suppliers. While other countries may offer lower prices, Brazil's consistent quality and reliability make it a preferred choice for Indian importers.
Indian importers face several supply chain risks when sourcing Amphotericin formulations from Brazil, including:
To mitigate these risks, importers should conduct thorough due diligence, maintain diversified supplier relationships, and implement robust risk management strategies.
To optimize procurement of Amphotericin formulations from Brazil, Indian buyers should consider the following actionable points:
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Amphotericin suppliers from BRAZIL to India include NEWARIS LIFESCIENCES, M/S SUN FARMACEUTICA DO BRASIL LTDA, EUROFARMA LABORATORIOS S A. The leading supplier is NEWARIS LIFESCIENCES with import value of $171.6K USD across 1 shipments. India imported Amphotericin worth $271.0K USD from BRAZIL in total across 8 shipments.
India imported Amphotericin worth $271.0K USD from BRAZIL across 8 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Amphotericin sourced from BRAZIL include EMCURE PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED. The largest buyer is EMCURE PHARMACEUTICALS LIMITED with $171.6K in imports across 1 shipments.
The total value of Amphotericin imports from BRAZIL to India is $271.0K USD, across 8 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
5 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists